New Severe Asthma Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved Cinqair (reslizumab) to manage severe asthma.
Could Colds Be Behind Asthma Hospitalizations?
Right after schools reopen after break could be the most dangerous time of year for children with asthma, new evidence suggests. And the reason why may surprise you.
A New Rx for Chronic Sinusitis
Scientists don't know exactly what causes nasal polyps to grow. But they may have developed an effective treatment for these bothersome growths.
Cystic Fibrosis: Catching It Early
When screening for cystic fibrosis (CF) in newborns, time is of the essence. And a new screening test could cut the current wait time for results in half.
In Late Preterm Births, This Rx Could Help Baby's Lungs
Doctors have prescribed steroids to pregnant women at risk of preterm delivery for decades. But what about those at risk of late preterm delivery?
Vitamin D in Moms-to-Be: The Effect on Kids' Asthma
Could the vitamin D in mom's diet during pregnancy affect her children's future health? Regarding asthma, that question might have been answered.
The Asthma-Shingles Connection
Ever had chickenpox? If so, you're at risk of shingles. But you may be at an even higher risk if you also have this common condition.
For Cancer Pain, What Rx Is Best?
For patients struggling with cancer-related pain, what pain relievers are best? The answer may not be so black and white.
Uptravi Approved for Pulmonary Arterial Hypertension (PAH)
The U.S. Food and Drug Administration today approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.
The Asthma-Migraine Connection
If you have asthma, you may be more likely to develop another common condition.